Use este identificador para citar ou linkar para este item:
http://www.repositorio.cdtn.br:8080/jspui/handle/123456789/438
Título: | Investigation of chemical impurities in formulation, phytotherapics and polyvitaminic medicines by k0-instrumental neutron activation analysis |
Título do periódico: | Nuclear Instruments and Methods in Physics Research Amsterdam |
Sub título do periódico: | Accellerators, Spectrometers, Detectors and Associated Equipment |
Autor(es): | Leal, Alexandre Soares Menezes, Maria Ângela de Barros Correia Vermaercke, L.D. Sneyer, L. Jensen, C.E.M. |
Afiliação: | Centro de Desenvolvimento da Tecnologia Nuclear/CDTN, Belo Horizonte, MG, Brasil Centro de Desenvolvimento da Tecnologia Nuclear/CDTN, Belo Horizonte, MG, Brasil SCK CEN Belgian Nuclear Research Centre, Mol, Belgium SCK.CEN Belgian Nuclear Research Centre, Mol, Belgium Centro Universitário Newton Paiva , Belo Horizonte, MG, Brasil |
Data do documento: | 2006 |
Palavras-chave: | Neutron activation analysis;drugs;medicinal plants |
Resumo: | In this work, comparative k0-Instrumental Neutron-Activation Analysis was performed by CDTN/CNEN/Brazil and SCK.CEN/Belgium in order to investigate the elemental concentration in samples of the same industrialised and manipulated medicine, a phytotherapic and a polyvitaminic, commonly commercialised in Brazil. The preliminary results from both Institutes are in very good agreement. Any serious contamination with possible risks to human health were found in the medicines compared with the expected values. In the case of polyvitaminic, some impurities, unexpected elements, such as La, Ti and Sm, were found in very low concentration. This first assessment confirmed the effectiveness of the k0-method in analysing such matrices. |
Acesso: | L |
Aparece nas coleções: | Artigo de periódico |
Arquivos associados a este item:
Arquivo | Descrição | Tamanho | Formato | |
---|---|---|---|---|
Art-03_Alexandre_SLeal.pdf | 101.8 kB | Adobe PDF | Visualizar/Abrir |
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.